Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2006 1
2008 1
2009 1
2010 2
2011 5
2012 3
2013 2
2014 8
2015 6
2016 9
2017 9
2018 7
2019 9
2020 3
2021 1
2022 5
2023 8
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

73 results

Results by year

Filters applied: . Clear all
Page 1
Oncolytic viruses: a new class of immunotherapy drugs.
Kaufman HL, Kohlhapp FJ, Zloza A. Kaufman HL, et al. Among authors: zloza a. Nat Rev Drug Discov. 2015 Sep;14(9):642-62. doi: 10.1038/nrd4663. Nat Rev Drug Discov. 2015. PMID: 26323545 Free PMC article. Review.
Combination oncolytic virus, radiation therapy, and immune checkpoint inhibitor treatment in anti-PD-1-refractory cancer.
Jhawar SR, Wang SJ, Thandoni A, Bommareddy PK, Newman JH, Marzo AL, Kuzel TM, Gupta V, Reiser J, Daniels P, Schiff D, Mitchell D, LeBoeuf NR, Simmons C, Goyal S, Lasfar A, Guevara-Patino JA, Haffty BG, Kaufman HL, Silk AW, Zloza A, Giurini EF. Jhawar SR, et al. Among authors: zloza a. J Immunother Cancer. 2023 Jul;11(7):e006780. doi: 10.1136/jitc-2023-006780. J Immunother Cancer. 2023. PMID: 37433716 Free PMC article.
Infection: a Cause of and Cure for Cancer.
Newman JH, Zloza A. Newman JH, et al. Among authors: zloza a. Curr Pharmacol Rep. 2017;3(6):315-320. doi: 10.1007/s40495-017-0109-y. Epub 2017 Oct 5. Curr Pharmacol Rep. 2017. PMID: 29201631 Free PMC article. Review.
Interferon Lambda: Toward a Dual Role in Cancer.
Lasfar A, Zloza A, Silk AW, Lee LY, Cohen-Solal KA. Lasfar A, et al. Among authors: zloza a. J Interferon Cytokine Res. 2019 Jan;39(1):22-29. doi: 10.1089/jir.2018.0046. Epub 2018 Jul 18. J Interferon Cytokine Res. 2019. PMID: 30020822 Review.
Talimogene laherparepvec (T-VEC) as cancer immunotherapy.
Kohlhapp FJ, Zloza A, Kaufman HL. Kohlhapp FJ, et al. Among authors: zloza a. Drugs Today (Barc). 2015 Sep;51(9):549-58. doi: 10.1358/dot.2015.51.9.2383044. Drugs Today (Barc). 2015. PMID: 26488034 Review.
A Spontaneous Melanoma Mouse Model Applicable for a Longitudinal Chemotherapy and Immunotherapy Study.
Eddy K, Gupta K, Pelletier JC, Isola AL, Marinaro C, Rasheed MA, Campagnolo J, Eddin MN, Rossi M, Fateeva A, Reuhl K, Shah R, Robinson AK, Chaly A, Freeman KB, Chen W, Diaz J, Furmanski P, Silk AW, Reitz AB, Zloza A, Chen S. Eddy K, et al. Among authors: zloza a. J Invest Dermatol. 2023 Oct;143(10):2007-2018.e6. doi: 10.1016/j.jid.2023.03.1664. Epub 2023 Mar 29. J Invest Dermatol. 2023. PMID: 36997110 Free article.
Oncolytic Viruses-Natural and Genetically Engineered Cancer Immunotherapies.
Jhawar SR, Thandoni A, Bommareddy PK, Hassan S, Kohlhapp FJ, Goyal S, Schenkel JM, Silk AW, Zloza A. Jhawar SR, et al. Among authors: zloza a. Front Oncol. 2017 Sep 11;7:202. doi: 10.3389/fonc.2017.00202. eCollection 2017. Front Oncol. 2017. PMID: 28955655 Free PMC article. Review.
IFN-lambda therapy: current status and future perspectives.
Lasfar A, Zloza A, Cohen-Solal KA. Lasfar A, et al. Among authors: zloza a. Drug Discov Today. 2016 Jan;21(1):167-171. doi: 10.1016/j.drudis.2015.10.021. Epub 2015 Nov 10. Drug Discov Today. 2016. PMID: 26552337 Review.
73 results